Scale Biosciences (Scale Bio), in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
The program, dubbed the "100 Million Cell Challenge," calls on researchers worldwide to submit proposals for large-scale single-cell projects. The projects selected for the initiative will receive early access to Scale Bio's newest workflow, QuantumScale, a single-cell RNA sequencing technology capable of processing up to 2 million cells per run. Ultima Genomics is providing high-throughput sequencing and Nvidia is providing access to its accelerated computing platform. These collaborations will help ensure that participating researchers have access to state-of-the-art resources throughout the entire workflow, Scale Bio said.
In a statement, Scale Bio noted that the challenge includes the following elements:
- A minimum project size of 1 million cells, with no maximum limit
- Collaboration with industry partners for sequencing and data analysis services
- Substantially subsidized costs for library preparation and sequencing services
Researchers interested in participating can submit their project proposals from August 8 to October 15, 2024. Projects will be evaluated on an ongoing basis as they are submitted. Selected projects will be announced at the American Society of Human Genetics Annual Meeting in November 2024.
For more information about the challenge or to submit a proposal, visit Scale Bio's site.
